(19)
(11) EP 3 681 507 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
13.03.2024 Bulletin 2024/11

(45) Mention of the grant of the patent:
07.02.2024 Bulletin 2024/06

(21) Application number: 18856299.5

(22) Date of filing: 06.09.2018
(51) International Patent Classification (IPC): 
A61K 31/56(2006.01)
A61P 3/00(2006.01)
A61P 3/06(2006.01)
A61P 21/00(2006.01)
A23L 33/105(2016.01)
C07C 62/32(2006.01)
 C07C 279/26(2006.01)
A61P 3/04(2006.01)
A61P 3/10(2006.01)
A23L 33/10(2016.01)
A61K 31/19(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/19; C07C 62/32; A23V 2002/00; A23L 33/10; C07C 2603/52; A23L 33/105; A61P 3/00; A61P 3/04; A61P 3/06; A61P 3/10; A61P 21/00
 
C-Sets:
A23V 2002/00, A23V 2200/306, A23V 2200/316, A23V 2200/326, A23V 2200/3262, A23V 2200/328, A23V 2250/02;
(86) International application number:
PCT/US2018/049742
(87) International publication number:
WO 2019/055280 (21.03.2019 Gazette 2019/12)

(54)

URSOLIC ACID MORPHOLINE AND DIETHANOLAMINE SALTS

URSOSÄUREMORPHOLIN- UND DIETHANOLAMINSALZE

SELS DE DIÉTHANOLAMINE ET DE MORPHOLINE D'ACIDE URSOLIQUE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 13.09.2017 US 201762558004 P
29.03.2018 US 201862649938 P

(43) Date of publication of application:
22.07.2020 Bulletin 2020/30

(73) Proprietor: Emmyon, Inc.
Rochester, MN 55902 (US)

(72) Inventor:
  • TALLEY, John J.
    St. Louis, Missouri 63109 (US)

(74) Representative: Hutchins, Michael Richard 
Schlich 9 St Catherine's Road
Littlehampton, West Sussex BN17 5HS
Littlehampton, West Sussex BN17 5HS (GB)


(56) References cited: : 
EP-A1- 1 321 145
KR-A- 20120 028 043
 WO-A1-2011/146768
US-A1- 2017 056 414
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).